OM-85 BV in pediatric recurrent respiratory tract infections: a cost-utility analysis

ABSTRACT: Background: Despite the growing evidence on efficacy, little is known regarding the cost-utility of Vaxom/Imocur (OM-85 BV) supplementation to decrease the probability of recurrent respiratory tract infections in OM-85 BV to reduce the incidence of recurrent respiratory tract infections in...

Full description

Autores:

Buendía Rodríguez, Jefferson Antonio
Lindarte Rincón, Erika Fernanda
Guerrero Patiño, Diana

Tipo de recurso:

Article of investigation

Fecha de publicación:

2022

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/45374

Acceso en línea:

https://hdl.handle.net/10495/45374

Palabra clave:

Niño
Child
Colombia
Análisis Costo-Beneficio
Cost-Benefit Analysis
Infecciones del Tracto Respiratorio
Respiratory Tract Infections
Economía y Organizaciones para la Atención de la Salud
Health Care Economics and Organizations
Corticoesteroides
Adrenal Cortex Hormones
https://id.nlm.nih.gov/mesh/D002648
https://id.nlm.nih.gov/mesh/D003105
https://id.nlm.nih.gov/mesh/D003362
http://id.nlm.nih.gov/mesh/D012141
https://id.nlm.nih.gov/mesh/D004472
https://id.nlm.nih.gov/mesh/D000305

Rights

openAccess

License

http://creativecommons.org/licenses/by/2.5/co/